Sep 2026
Germline EGFR T790M mutation and lung cancer risk.
J. LoPiccolo, S. Micheletti, Jingchunzi Shi et al.
· Science · 0 citations
We have 3 of 24 papers
We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.
Not the right person? Other researchers publish under this name.
Open access
Jul 2026
Germline determinants of risk and molecular subtype in young-onset lung cancer
A complex germline architecture underlying susceptibility and molecular subtype in young-onset lung cancer is delineated, consistent with additive risk from rare and common variants.
J. LoPiccolo, Ryan L. Collins, Noah Fields et al.
· medRxiv · 0 citations
Aug 2026
Therapeutic targeting of RAS-mediated resistance in oncogene-driven lung cancer.
RAS alterations mediate resistance to targeted agents in approximately 10% of oncogene-driven lung cancer, and Rational combinations with novel RAS inhibitors are effective in preclinical models, providing the basis for their clinical investigation and extending the paradigm of precision oncology.
F. Facchinetti, L. Friboulet, L. Liao et al.
· Annals of Oncology · 0 citations